FDA clears Medtronic brain stimulation for MR use

Interventional device developer Medtronic announced that the U.S. Food and Drug Administration (FDA) has cleared parts of its Activa portfolio of deep brain stimulation neurostimulators for full-body MRI scans.

The clearance expands patient access to care, making it safe to undergo MR exams while also undergoing deep brain stimulation therapy.

Medtronic's MR-conditional deep brain stimulation systems are the only ones that give patients access to full-body MRI scans, the company said.